Literature DB >> 35650421

Landscape of cancer cell therapies: trends and real-world data.

Ana Rosa Saez-Ibañez, Samik Upadhaya, Tanya Partridge, Monica Shah, Diego Correa, Jay Campbell.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35650421     DOI： 10.1038/d41573-022-00095-1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   112.288


× No keyword cloud information.
  5 in total

1.  The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex.

Authors:  Murielle N Wahli; Stefanie Hayoz; Dennis Hoch; Christoph O Ryser; Michèle Hoffmann; Amina Scherz; Birgit Schwacha-Eipper; Simon Häfliger; Julian Wampfler; Martin D Berger; Urban Novak; Berna C Özdemir
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-23       Impact factor: 4.322

Review 2.  Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.

Authors:  Tae Kon Kim; Esten N Vandsemb; Roy S Herbst; Lieping Chen
Journal:  Nat Rev Drug Discov       Date:  2022-06-14       Impact factor: 112.288

Review 3.  Emerging Trends in Immunotherapy for Cancer.

Authors:  Alok K Mishra; Amjad Ali; Shubham Dutta; Shahid Banday; Sunil K Malonia
Journal:  Diseases       Date:  2022-09-06

4.  Gene and cell therapies in China: booming landscape under dual-track regulation.

Authors:  Chen Yin; Jianchao Gao; Guanqiao Li; Hongxi Hu; Liyun Zhou; Shuang Lu; Xiaoyuan Chen
Journal:  J Hematol Oncol       Date:  2022-10-05       Impact factor: 23.168

5.  Editorial: Innate immune cell therapy of cancer.

Authors:  Natasha Khatwani; Rizwan Romee; Asha B Pillai
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.